United States · FDA National Drug Code directory
Thymoglobulin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58468-0080_1e694a66-3d88-498c-ae79-47bc6f1c7b7d
- Product NDC
- 58468-0080
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Anti-thymocyte Globulin (Rabbit)
- Labeler
- Genzyme Corporation
- Marketing category
- BLA
- Marketing start / end (source format)
- 19981230
- Source listing expiry
- 20271231
Source-listed ingredients
- LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (58468-0080-1) / 5 mL in 1 VIAL, GLASS · 58468-0080-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →